Viewing Study NCT05527704


Ignite Creation Date: 2025-12-24 @ 9:10 PM
Ignite Modification Date: 2026-04-14 @ 7:04 AM
Study NCT ID: NCT05527704
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-18
First Post: 2022-08-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial)
Sponsor: Medical University of Warsaw
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module